Japan · Delayed Price · Currency is JPY Towa Pharmaceutical Company Description
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan.
The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products.
The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs.
In addition, it is involved in research and development and production of active pharmaceutical ingredients, intermediates, and support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes.
Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Kadoma, Japan.
| Country | Japan |
| Founded | 1951 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4,923 |
| CEO | Itsuro Yoshida |
Contact Details
Address: 2-11, Shinbashi-cho Kadoma, 571-8580 Japan | |
| Phone | 81 6 6900 9100 |
| Website | towayakuhin.co.jp |
Stock Details
| Ticker Symbol | 4553 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3623150004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Itsuro Yoshida | Chief Executive Officer |
| Shiro Hatagami | Chief Financial Officer |